Pesquisa

Publicações

Publicações

de Alencar VTL, Figueiredo AB, Corassa M, Gollob KJ, Cordeiro de Lima VC. Lung cancer in never smokers: Tumor immunology and challenges for immunotherapy. Front Immunol. 2022 Aug 24;13:984349. DOI: 10.3389/fimmu.2022.984349

de Britto Evangelista GF, Figueiredo AB, de Barros E Silva MJ, Gollob KJ. Balancing the good and the bad: controlling immune-related adverse events versus anti-tumor responses in cancer patients treated with immune checkpoint inhibitors. Immunother Adv. 2022 Apr 8;2(1):ltac008. DOI: 10.1093/immadv/ltac008. eCollection 2022.

Publicações

Lopes, A. D., Galdino, N. A. L., Figueiredo, A. B., Brianese, R. C., Morais, K. L. P., De Brot, M., Osório, C. A. B. T., Teixeira-Carvalho, A., Calsavara, V. F., Evangelista, G. F. B., Alves, N. S., Makdissi, F. B., Sanches, S. M., Cordeiro de Lima, V. C., Carraro, D. M., & Gollob, K. J. (2023). Systemic immune mediators reflect tumour-infiltrating lymphocyte intensity and predict therapeutic response in triple-negative breast cancer. Immunology, 169(2), 229–241. DOI: https://doi.org/10.1111/imm.13627

Martins, P., Morais, K. L., De Lima Galdino, N. A., Jacauna, A., De Paula, S. O. C., Magalhães, W. C. S., Zuccherato, L. W., Campos, L. S., De Oliveira Salles, P. G., & Gollob, K. J. (2023). Linking tumor immune infiltrate and systemic immune mediators to treatment response and prognosis in advanced cervical cancer. Scientific Reports, 13(1). DOI: https://doi.org/10.1038/s41598-023-49441-2